9-5339688-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006911.4(RLN1):c.59C>T(p.Ser20Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006911.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RLN1 | NM_006911.4 | c.59C>T | p.Ser20Phe | missense_variant | 1/2 | ENST00000223862.2 | NP_008842.1 | |
RLN1 | XM_047423703.1 | c.59C>T | p.Ser20Phe | missense_variant | 1/3 | XP_047279659.1 | ||
RLN1 | XM_047423706.1 | c.-48+1133C>T | intron_variant | XP_047279662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RLN1 | ENST00000223862.2 | c.59C>T | p.Ser20Phe | missense_variant | 1/2 | 1 | NM_006911.4 | ENSP00000223862.1 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 151546Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251368Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135868
GnomAD4 exome AF: 0.000222 AC: 324AN: 1461658Hom.: 0 Cov.: 31 AF XY: 0.000248 AC XY: 180AN XY: 727142
GnomAD4 genome AF: 0.000132 AC: 20AN: 151664Hom.: 0 Cov.: 27 AF XY: 0.0000539 AC XY: 4AN XY: 74174
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.59C>T (p.S20F) alteration is located in exon 1 (coding exon 1) of the RLN1 gene. This alteration results from a C to T substitution at nucleotide position 59, causing the serine (S) at amino acid position 20 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at